Cigna Says Bristol-Myers Delayed Cancer Drug Generic

By Gianna Ferrarin · June 25, 2025, 8:56 PM EDT

Cigna has launched an antitrust suit in New York federal court accusing Bristol-Myers Squibb Co. and its Celgene subsidiary of fraudulently obtaining patents, filing sham litigation and paying off generic-drug makers...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login